Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Somnigroup International Inc., operating as Somni, leads the field in advanced sleep technology and holistic wellness solutions. They engineer groundbreaking products specifically designed to elevate sleep quality. Their approach seamlessly integrates scientifically validated methods, intelligent technology, and data-driven insights to optimize sleep patterns and foster overall well-being.
Somnigroup International Inc., operating as Somni, leads the field in advanced sleep technology and holistic wellness solutions. They engineer groundbreaking products specifically designed to elevate sleep quality. Their approach seamlessly integrates scientifically validated methods, intelligent technology, and data-driven insights to optimize sleep patterns and foster overall well-being.
| Metric | 5Yr Avg | Sep '23 | Mar '24 | Nov '25 | May '26 | Oct '26 | |
|---|---|---|---|---|---|---|---|
PRICE-BASED RATIOS | |||||||
| Price / Earnings | 78.51 | 16.63 | 26.58 | 118.89 | 105.35 | 125.11 | |
| Price / Sales | 6.12 | 1.54 | 1.99 | 11.89 | 7.94 | 7.24 | |
| Price / Book Value | -55.29 | -342.99 | 30.25 | 27.38 | 4.77 | 4.14 | |
| Price / Free Cash Flow | 125.12 | 104.84 | 25.42 | 64.35 | 360.92 | 70.09 | |
ENTERPRISE VALUE METRICS | |||||||
| Enterprise Value | 16,925.7 | 10,889.9 | 12,985.8 | 18,312.4 | 22,972.5 | 19,467.9 | |
| Enterprise Value / Sales | 8.41 | 2.21 | 2.64 | 14.09 | 12.30 | 10.81 | |
| Enterprise Value / EBITDA | 49.91 | 13.49 | 17.56 | 75.17 | 67.91 | 75.40 | |
| Enterprise Value / EBIT | 63.24 | 16.01 | 21.50 | 90.93 | 89.08 | 98.67 | |
| Millions USD | 5Yr CAGR (%) | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
INCOME STATEMENT | |||||||
| Revenue | 11% | 4,930.8 | 4,921.2 | 4,925.4 | 4,930.9 | 7,476.5 | |
| Gross Income | 11.3% | 2,158.7 | 2,049.6 | 2,128.7 | 2,180.1 | 3,315.9 | |
| EBITDA | 90.9% | 1,003.5 | 807.3 | 739.3 | 804.2 | 1,040.5 | |
| EBIT | -4.2% | 890.3 | 680.2 | 604.0 | 639.1 | 748.9 | |
| Net Income | -11.4% | 624.5 | 455.7 | 368.1 | 384.3 | 384.1 | |
| EPS (Diluted) | -11.9% | 3.06 | 2.53 | 2.08 | 2.16 | 1.84 | |
BALANCE SHEET | |||||||
| Cash & ST Inv | -18.2% | 300.7 | 69.4 | 74.9 | 117.4 | 134.9 | |
| Total Assets | 28% | 4,323.4 | 4,359.8 | 4,553.9 | 5,980.4 | 11,614.0 | |
| Total Liabilities | 20.5% | 4,028.4 | 4,372.1 | 4,220.5 | 5,412.1 | 8,497.1 | |
| Total Shareholder Equity | 81.6% | 285.8 | -22.1 | 323.4 | 559.0 | 3,108.0 | |
CASH FLOW | |||||||
| Net Operating Cash Flow | 2.6% | 723.1 | 378.8 | 570.3 | 666.5 | 800.1 | |
| Cap Ex | 7.9% | -123.3 | -306.5 | -185.4 | -97.3 | -166.9 | |
| Free Cash Flow | 1.4% | 599.8 | 72.3 | 384.9 | 569.2 | 633.2 | |
Somnigroup International Inc., operating as Somni, leads the field in advanced sleep technology and holistic wellness solutions. They engineer groundbreaking products specifically designed to elevate sleep quality. Their approach seamlessly integrates scientifically validated methods, intelligent technology, and data-driven insights to optimize sleep patterns and foster overall well-being.
Somnigroup International Inc., operating as Somni, leads the field in advanced sleep technology and holistic wellness solutions. They engineer groundbreaking products specifically designed to elevate sleep quality. Their approach seamlessly integrates scientifically validated methods, intelligent technology, and data-driven insights to optimize sleep patterns and foster overall well-being.
| Metric | 5Yr Avg | Sep '23 | Mar '24 | Nov '25 | May '26 | Oct '26 | |
|---|---|---|---|---|---|---|---|
PRICE-BASED RATIOS | |||||||
| Price / Earnings | 78.51 | 16.63 | 26.58 | 118.89 | 105.35 | 125.11 | |
| Price / Sales | 6.12 | 1.54 | 1.99 | 11.89 | 7.94 | 7.24 | |
| Price / Book Value | -55.29 | -342.99 | 30.25 | 27.38 | 4.77 | 4.14 | |
| Price / Free Cash Flow | 125.12 | 104.84 | 25.42 | 64.35 | 360.92 | 70.09 | |
ENTERPRISE VALUE METRICS | |||||||
| Enterprise Value | 16,925.7 | 10,889.9 | 12,985.8 | 18,312.4 | 22,972.5 | 19,467.9 | |
| Enterprise Value / Sales | 8.41 | 2.21 | 2.64 | 14.09 | 12.30 | 10.81 | |
| Enterprise Value / EBITDA | 49.91 | 13.49 | 17.56 | 75.17 | 67.91 | 75.40 | |
| Enterprise Value / EBIT | 63.24 | 16.01 | 21.50 | 90.93 | 89.08 | 98.67 | |
| Millions USD | 5Yr CAGR (%) | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
INCOME STATEMENT | |||||||
| Revenue | 11% | 4,930.8 | 4,921.2 | 4,925.4 | 4,930.9 | 7,476.5 | |
| Gross Income | 11.3% | 2,158.7 | 2,049.6 | 2,128.7 | 2,180.1 | 3,315.9 | |
| EBITDA | 90.9% | 1,003.5 | 807.3 | 739.3 | 804.2 | 1,040.5 | |
| EBIT | -4.2% | 890.3 | 680.2 | 604.0 | 639.1 | 748.9 | |
| Net Income | -11.4% | 624.5 | 455.7 | 368.1 | 384.3 | 384.1 | |
| EPS (Diluted) | -11.9% | 3.06 | 2.53 | 2.08 | 2.16 | 1.84 | |
BALANCE SHEET | |||||||
| Cash & ST Inv | -18.2% | 300.7 | 69.4 | 74.9 | 117.4 | 134.9 | |
| Total Assets | 28% | 4,323.4 | 4,359.8 | 4,553.9 | 5,980.4 | 11,614.0 | |
| Total Liabilities | 20.5% | 4,028.4 | 4,372.1 | 4,220.5 | 5,412.1 | 8,497.1 | |
| Total Shareholder Equity | 81.6% | 285.8 | -22.1 | 323.4 | 559.0 | 3,108.0 | |
CASH FLOW | |||||||
| Net Operating Cash Flow | 2.6% | 723.1 | 378.8 | 570.3 | 666.5 | 800.1 | |
| Cap Ex | 7.9% | -123.3 | -306.5 | -185.4 | -97.3 | -166.9 | |
| Free Cash Flow | 1.4% | 599.8 | 72.3 | 384.9 | 569.2 | 633.2 | |